Pregnancy and assisted reproductive technology use in Australian female transfusion‐dependent haemoglobinopathy patients: a 20‐year retrospective analysis

Abstract

AbstractBackgroundIn the last few decades, the life expectancy of patients with transfusion‐dependent thalassaemia (TDT) and sickle cell disease (SCD) has improved significantly, in part because of improved iron chelation. Fertility challenges and pregnancy complications have historically limited reproductive options in this group; however, improved multi‐disciplinary care has made infertility a chronic disease complication requiring attention. Despite this, there are very few reports and no Australian data describing fertility and pregnancy outcomes in this population.AimsTo identify the rate of assisted reproductive technologies (ART) utilisation in our female transfusion‐dependent haemoglobinopathy patients and to establish the nature of maternal and neonatal complications in this cohort.MethodsA 20‐year retrospective analysis (1997–2017) at an Australian centre captured data on conception rates, use of assisted reproductive techniques (ART), and pregnancy and neonatal outcomes in female transfusion‐dependent haemoglobinopathy patients.ResultsConception was attempted in 14 women (11 TDT and three SCD) during the study period. A total of 28 pregnancies resulting in 25 live births were recorded. ART supported 13 conceptions. A positive association was not identified between elevated mean serum ferritin and ART use; however, all patients with an established diagnosis of hypogonadotropic hypogonadism (HH) required ART. Maternal complications included gestational diabetes mellitus and post‐partum haemorrhage. There were no cardiac complications. Two‐thirds of women underwent lower segment caesarean section, with prematurity complicating 20% of births. There were no neonatal or maternal deaths.ConclusionPregnancy is an achievable goal for women with transfusion‐dependent haemoglobinopathies, although the support of ART may be required in a subset of patients.